Enanta Pharmaceuticals (ENTA) Net Margin Growth (3y) (2015 - 2026)
Enanta Pharmaceuticals (ENTA) Net Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,283.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 4,144.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - | 13,533.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,533.00 |
| Dec 31, 2025 | 5,877.00 |
| Sep 30, 2025 | 605.00 |
| Jun 30, 2025 | 6,306.00 |
| Mar 31, 2025 | 2,777.00 |
| Dec 31, 2024 | -2,251.00 |
| Sep 30, 2024 | 15,009.00 |
| Jun 30, 2024 | -1,498.00 |
| Mar 31, 2024 | -256.00 |
| Dec 31, 2023 | -15,933.00 |
| Sep 30, 2023 | -1,098.00 |
| Jun 30, 2023 | -13,031.00 |
| Mar 31, 2023 | -18,988.00 |
| Dec 31, 2022 | -14,847.00 |
| Sep 30, 2022 | -14,760.00 |
| Jun 30, 2022 | -17,860.00 |
| Mar 31, 2022 | -18,994.00 |
| Dec 31, 2021 | -14,614.00 |
| Sep 30, 2021 | -38,822.00 |
| Jun 30, 2021 | -14,653.00 |